Neuroprotective effects of p62(SQSTM1)-engineered lactic acid bacteria in Alzheimer's disease: a pre-clinical study.
Cecarini V, Bonfili L, Gogoi O, Lawrence S, Venanzi FM, Azevedo V, Mancha-Agresti P, Drumond MM, Rossi G, Berardi S, Galosi L, Cuccioloni M, Angeletti M, Suchodolski JS, Pilla R, Lidbury JA, Eleuteri AM.
Cecarini V, et al. Among authors: pilla r.
Aging (Albany NY). 2020 Aug 28;12(16):15995-16020. doi: 10.18632/aging.103900. Epub 2020 Aug 28.
Aging (Albany NY). 2020.
PMID: 32855357
Free PMC article.